Tough Flu Season Ahead: Vaccine May Only Be 10% Effective
WEDNESDAY, Dec. 6, 2017 -- There ' s bad news about this year ' s flu vaccine.
The most common type of flu being seen in the United States is influenza A H3N2, the same severe strain that dominated last flu season.
And in Australia, where the winter... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 6, 2017 Category: General Medicine Source Type: news
Tough Flu Season Ahead: Vaccine May Only Be 10 & #37; Effective
WEDNESDAY, Dec. 6, 2017 -- There ' s bad news about this year ' s flu vaccine.
The most common type of flu being seen in the United States is influenza A H3N2, the same severe strain that dominated last flu season.
And in Australia, where the winter flu... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 6, 2017 Category: General Medicine Source Type: news
This year's flu set to be one of the worst ever
The US will be hit by the H3N2 flu strain this year - the same strain responsible for the biggest outbreaks in recent history and the one that has just wreaked havoc in Australia. (Source: the Mail online | Health)
Source: the Mail online | Health - December 5, 2017 Category: Consumer Health News Source Type: news
Experts Concerned About Effectiveness Of This Year ’ s Flu Vaccine
(CNN) — Last year’s seasonal flu vaccine effectiveness was just 42%, the US Centers for Disease Control and Prevention estimated. Even if vaccinated, people had inadequate protection against the flu.
This limited effectiveness was due to a mutation that occurred in the influenza A (H3N2) vaccine strain, according to a study published Monday in the journal Proceedings of the National Academy of Sciences. This vaccine mutation resulted from an egg-based manufacturing process commonly used today.
This year’s flu vaccine may also be imperfect, said Scott Hensley, author of the new study and an associate profe...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 8, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Flu Flu Vaccine Local TV Source Type: news
Flu season is here and experts are already concerned
Last season's flu vaccine had limited effectiveness in part due to a mutation that occurred in the H3N2 vaccine strain -- a result of the manufacturing process. (Source: CNN.com - Health)
Source: CNN.com - Health - November 8, 2017 Category: Consumer Health News Source Type: news
Flu vaccine may only be 20% effective this winter
H3N2, the same strain which caused havoc in Australia and triggered an influx of flu cases during their winter, has mutated, according to researchers at the University of Pennsylvania. (Source: the Mail online | Health)
Source: the Mail online | Health - November 7, 2017 Category: Consumer Health News Source Type: news
H3N2 Virus in Swine at Fairs and Transmission to Humans H3N2 Virus in Swine at Fairs and Transmission to Humans
Human influenza A virus infections were reported after exposure to infected swine at agricultural fairs.Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 6, 2017 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news
H3N2 mutation in last year's flu vaccine responsible for lowered efficacy
(University of Pennsylvania School of Medicine) The below average efficacy of last year's influenza vaccine (which was only 20 to 30 percent effective) can be attributed to a mutation in the H3N2 strain, a new study reports. With the mutation, most people receiving the egg-grown vaccine did not have immunity against H3N2 viruses that circulated last year. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 6, 2017 Category: Infectious Diseases Source Type: news
UGA, Sanofi Pasteur develop new broadly protective vaccines for H3N2 influenza
(University of Georgia) Researchers have developed a vaccine candidate that protects against multiple co-circulating strains of H3N2 influenza isolated over five seasons following testing in mouse and ferret models. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 2, 2017 Category: International Medicine & Public Health Source Type: news
Moderate Influenza Season to Come, New Model Predicts Moderate Influenza Season to Come, New Model Predicts
A computational tool wedding viral evolution and epidemiology predicted an above-average H3N2 influenza season in 2017 to 2018, but not as severe as last year (which the model accurately predicted).Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 25, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Aussie flu will strike UK badly this winter warns scholar
Chris Kutarna, author and research fellow at Oxford University, writing in his new book said 'it is going to be a severe flu season'. Experts are also concerned about the H3N2 strain. (Source: the Mail online | Health)
Source: the Mail online | Health - October 16, 2017 Category: Consumer Health News Source Type: news
Interim Estimate Suggests Flu Shot Not Effective in 2021 - 2022 Season
Vaccine effectiveness against medically attended outpatient acute respiratory infection associated with A(H3N2) was 16 percent (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 12, 2017 Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Infections, Internal Medicine, Nursing, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news
Aussie flu could kill as many as 1968 Hong Kong pandemic
Professor Robert Dingwall, a public health expert at Nottingham Trent University, said it is 'inevitable' the H3N2 strain which has caused havoc in Australia will reach Britain. (Source: the Mail online | Health)
Source: the Mail online | Health - September 25, 2017 Category: Consumer Health News Source Type: news
Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial
This study has led to a Practice Changing Update on DynaMed Plus. It found that clarithromycin plus naproxen plus oseltamivir for 2 days followed by oseltamivir for 3 days may reduce mortality compared to oseltamivir alone for 5 days in hospitalized older adults with influenza A (H3N2) and pneumonia (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 29, 2017 Category: Consumer Health News Source Type: news
'Painless' flu vaccine skin patch shows promise
Conclusion
Further testing in larger trials needs to be done to be sure these initial results hold true and that the vaccine patch is safe and effective. This is the first time these flu microneedle patches have been tested on humans, and the study was relatively small, with only 100 participants.
But if the results are confirmed, this new method of delivering the flu vaccination could make a big difference. The patches could have several main advantages over traditional injections:
they may be preferred by people who dislike needles and avoid vaccination because of the fear of pain
it may be quicker and easier to ad...
Source: NHS News Feed - June 28, 2017 Category: Consumer Health News Tags: Medical practice Medication Swine flu Source Type: news
